How IL-33 plays a key role in enabling the marathon runners of the immune system


When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.

GPs left psychologically distressed and overwhelmed by pressures of the pandemic, new study finds

Previous article

Deep-learning-based anatomical landmark identification in CT scans

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations